Search Results 3011-3020 of 34209 for oral

  1. Nizubaglusta in Late-Infantile and Juvenile Forms of Niemann-Pick Type C Disease and GM1 Gangliosidosis or GM2 Gangliosidosis - Mayo Clinic

    The purpose of this study is to demonstrate superior efficacy on ataxic manifestations with oral nizubaglustat dosing compared with placebo when ...

  2. Publications - Andrew S. Tseng, M.D. - Mayo Clinic

    ... oral anticoagulants post-percutaneous coronary intervention. Eur Heart J 2020 May 1; 41 (17):1700. View PubMed; Tseng AS, Shamoun FE, Marks LA, Agrwal N ...

  3. Untitled

    Page 1. Page 2. Page 3.

  4. Clinical Trial Enzyme Application Targeting Venous Leg Ulcers

    ... (oral, intravaginal, transdermal) or progestogen-only hormonal contraception (oral, injectable, implantable) associated with inhibition of ovulation ...

  5. TEPEZZA® (Teprotumumab-trbw) Post-Marketing Requirement Study - Mayo Clinic

    ... oral contraceptive. Hormonal contraception must be started at least 1 full cycle prior to Baseline and continue for 180 days after the last dose of ...

  6. Effects of Energy Drinks on Sleep and Cardiovascular Health - Mayo Clinic

    Subjects currently taking medications other than oral contraceptive pill. Smokers. Prior history of caffeine sensitivity or allergy. Pregnancy. Subjects who ...

  7. Development of Biomarkers Differentiating Post-infectious From Neurodegenerative Smell Loss - Mayo Clinic

    Age-matched healthy controls. Exclusion Criteria: Unable to undergo nasal endoscopy or CT scan. Pregnant women. Patients on chronic oral steroid therapy, oral ...

  8. Mayo Clinic Q and A: Women Should Talk to Doctor About Possible Health Risks if Exposed to DES in Utero

    However, it's a good idea to talk with your doctor about your DES exposure before you use any type of hormone replacement therapy or oral contraceptives. If ...

  9. Osteomyelitis - Symptoms and causes - Mayo Clinic

    Bones don't get infected easily, but a serious injury, bloodstream infection or surgery may lead to a bone infection.

  10. Rituximab in Progressive IgA Nephropathy - Mayo Clinic

    ... oral antibiotics within 2 weeks prior to screening; Ongoing use of high dose steroids(>10 mg/day)or unstable steroid dose in the past 4 weeks; Lack of ...